Techniques to Prevent Central Venous Catheter Infections: Products,Research,and Recommendations

Abstract

Central venous catheters (CVCs) are commonly used to deliver a variety of therapies such as chemotherapy and parenteral nutrition. It is well known that there are complications associated with CVCs; a major complication is catheter-related bloodstream infection (CRBSI). Many strategies exist to prevent CVC complications and CRBSI. This paper will focus on the fight against CRBSI using 3 products at the catheter insertion site: 2% chlorhexidine, BioPatch, and transparent split dressings. Lists of key recommendations from national organizations for infection prevention are included.

Get full access to this article

View all access options for this article.

References

Crnich CJ, Maki DG. The promise of novel technology for the prevention of intravascular device-related bloodstream infection: pathogenesis and short term devices. Clin Infect Dis. 2002 ;34:1232– 1242.

Crnich CJ, Maki DG. The promise of novel technology for the prevention of intravascular device-related bloodstream infection: long-term devices. Clin Infect Dis. 2002 ;34:1362– 1368.

O'Grady NP, Alexander M, Dellinger EP, et al. Guidelines for the prevention of intravascular catheter-related infections. MMWR Recomm. 2002;51:1– 29.

Hend HA, Raad I. Blood products: a significant risk factor for long-term catheter-related bloodstream infections in cancer patients. Infect Control Hosp Epidemiol. 200l ;22:165– 166.

Chaiyakunapruk N, Veenstra DL, Lipsky BA, Saint S. Chlorhexidine compared with povidone-iodine solution for vascular catheter-site care: a meta-analysis. Ann Intern Med. 2002 ;136:792– 801.

Maki DG, Mermel LA, Kluger D, et al. The efficacy of a chlorhexidine-impregnated sponge (Biopatch) for the prevention of intravascular catheter-related infection: a prospective, randomized, controlled, multicenter study [abstract]. 40^th Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington, DC, September 2000. Abstract 1430, page422 .

Crawford AG, Fuhr JP, Rao B. Cost-benefit analysis of chlorhexidine gluconate dressing in the prevention of catheter-related bloodstream infections. Infect Control Hosp Epidemiol. 2004 ;25:668– 674.

Safdar N, Maki DG. Inflammation at the insertion site is not predictive of catheter-related bloodstream infection with short-term, noncuffed central venous catheters. Crit Care Med. 2002 ;30:2632– 2635.

A.S.P.E.N. Board of Directors and Clinical Guidelines Task Force. Guidelines for the use of parenteral and enteral nutrition in adult and pediatric patients. JPEN J Parenter Enteral Nutr. 2002 ;26(suppl):36S– 37S.

10.

Banton J, Banning V. Impact on catheter-related bloodstream infections with the use of the BioPatch dressing. J Vascular Access Devices. 2002;7:1– 6.

11.

Mirtallo J, Canada T, Johnson D, et al. Safe practices for parenteral nutrition. JPEN J Parenter Enteral Nutr. 2004 ;28(suppl):S39– S70.

12.

Fauerbach LL, Gross MA, Ruse C, Kelly R. The quest for the irreducible minimum: 8 years of performance improvement in preventing central line-associated infections in a surgical intensive care unit [abstract]: APIC annual meeting June 21, 2005, Baltimore, MD. Abstract 54576.